Patient characteristics (n = 51) | |
Age ± SD (y) | 69 ± 11 |
Male, n (%) | 43 (84.3) |
Hypertension, n (%) | 36 (70.6) |
Hypercholesterolemia, n (%) | 33 (64.7) |
Diabetes, n (%) | 12 (23.5) |
Current smoker, n (%) | 5 (9.8) |
Family history of cardiovascular disease, n (%) | 15 (29.4) |
Risk factors for carotid endarterectomy | |
Previous carotid endarterectomy, n (%) | 15 (29.4) |
Contralateral carotid artery occlusion, n (%) | 14 (27.5) |
Previous radical neck dissection or radiation therapy in neck region, n (%) | 6 (11.8) |
Target lesion above C2 (level of jaw), n (%) | 2 (3.9) |
Low cervical carotid lesions, n (%) | 2 (3.9) |
Dissection, n (%) | 0 (0.0) |
Inability to extend the neck, n (%) | 2 (3.9) |
Tandem lesions ≥70% stenosis, n (%) | 6 (11.8) |
Contralateral laryngeal palsy, n (%) | 0 (0.0) |
At risk for wound infection, n (%) | 0 (0.0) |
Tracheostomy, n (%) | 2 (3.9) |
Patients >80 years of age, n (%) | 8 (15.7) |
Myocardial infarction within previous 6 weeks, n (%) | 1 (2.0) |
Unstable angina (according to Braunwald classification), n (%) | 5 (9.8) |
Severe renal failure (serum creatinine >2 mg/dL), n (%) | 0 (0.0) |
Elective coronary artery bypass grafting scheduled (≥30 days after procedure), n (%) | 1 (2.0) |
New York Heart Association class III or IV heart failure, n (%) | 7 (13.7) |
COPD with FEV1 <30% predicted, n (%) | 2 (3.9) |
History of liver failure with elevated prothrombin time | 0 (0.0) |
Note:—COPD indicates chronic obstructive pulmonary disease; FEV1, forced expiration volume in 1 second.